Lexagene Holdings (Lexagene Holdings) EV-to-Revenue : 116.46 (As of May. 02, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lexagene Holdings's enterprise value is $12.23 Mil. Lexagene Holdings's Revenue for the trailing twelve months (TTM) ended in Nov. 2022 was $0.11 Mil. Therefore, Lexagene Holdings's EV-to-Revenue for today is 116.46.

The historical rank and industry rank for Lexagene Holdings's EV-to-Revenue or its related term are showing as below:

LXXGQ's EV-to-Revenue is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 3.155
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-02), Lexagene Holdings's stock price is $0.0806. Lexagene Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2022 was $0.00. Therefore, Lexagene Holdings's PS Ratio for today is .

Lexagene Holdings EV-to-Revenue Historical Data

The historical data trend for Lexagene Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings EV-to-Revenue Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

EV-to-Revenue

Get a 7-Day Free Trial

1,656.77

367.82

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
EV-to-Revenue	Get a 7-Day Free Trial															298.51	367.82	225.92	182.46	221.32

Competitive Comparison of Lexagene Holdings's EV-to-Revenue

For the Medical Devices subindustry, Lexagene Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's EV-to-Revenue falls into.

Lexagene Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lexagene Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	12.228	/	0.105
	=	116.46

Lexagene Holdings's current Enterprise Value is $12.23 Mil.
Lexagene Holdings's Revenue for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11 Mil.

Lexagene Holdings (OTCPK:LXXGQ) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lexagene Holdings's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.0806	/	0
	=

Lexagene Holdings's share price for today is $0.0806.
Lexagene Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.

Lexagene Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.